Italy · Delayed Price · Currency is EUR TransMedics Group Company Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body.
Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers.
The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity.
The company was founded in 1998 and is headquartered in Andover, Massachusetts.
| Country | United States |
| Founded | 1998 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 728 |
| CEO | Waleed Hassanein |
Contact Details
Address: 200 Minuteman Road Andover, Massachusetts 01810 United States | |
| Phone | 978 552 0900 |
| Website | transmedics.com |
Stock Details
| Ticker Symbol | 1TMDX |
| Exchange | Borsa Italiana |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Waleed Hassanein | Chief Executive Officer |
| Gerardo Hernandez | Chief Financial Officer |
| Nicholas Corcoran | Chief Operating Officer |